njtc venture fund phillip p chan md phd 80 million early stage regional focus invest in a broad range of industries third the will be invested healthcare and life sciences vf investment pace currently 19 portfolio companies with target 30 35 these 7 are or science related 1 seed 4 2 expansion typical initial is 100 500k for 2m 5 5m later we typically reserve 3 4m total per anticipate additional investments this sector ideal general criteria strong game changing solid ip experienced credible management good visibility on whether not product work large addressable markets clear market need regulatory strategy well defined clinical endpoints understanding reimbursement issues true competitive advantage effectiveness cost etc buy from thought leaders low capital intensive opportunity initiative looking to make 6 approximately each launch new talented entrepreneurs next 12 months
